CORONAVIRUS, Government, Oregon

FDA approves Johnson & Johnson’s vaccine for emergency use

Ansu Drammeh, R.N., a cardiovascular intensive care nurse at OHSU, is given the Pfizer-BioNTech vaccine on Wednesday, December 16 by Ryan Thrower, D.M.D., who, according to OHSU, is the first dental resident in the United States to administer a COVID-19 vaccine.

The Food and Drug Administration approved the Johnson & Johnson vaccine for emergency use Saturday, adding a third vaccine to the U.S. effort to combat the novel coronavirus.

Unlike the Pfizer-BioNTech and the Moderna vaccines, Johnson & Johnson’s vaccine requires just a single shot. In clinical trials in the U.S., the vaccine boasted a 72% efficacy rate, lower than the first two vaccines, but still well above benchmarks set by the FDA. 

“Don’t get caught up, necessarily, on the number game, because it’s a really good vaccine, and . . .

You have reached content available exclusively to Banks Post digital subscribers.

We rely on subscribers to keep the lights on in our independent newsroom. Join us with a digital subscription today.

Click here to subscribe.

Receive a 3-day free trial of unlimited digital access.

Already a subscriber? Login here.

Newsletter

The groceries your family needs!